Sophia Genetics SA announced that AZ Delta Roeselare, one of the largest hospitals in Flanders, Belgium, has joined the SOPHiA GENETICS community. AZ Delta Roeselare is expanding its precision medicine capabilities by adopting a broad range of applications on the SOPHiA DDM™ Platform. The hospital will use the platform to advance data-driven medicine across blood and solid tumor indications, utilizing both germline and somatic solutions to support insights into complex diseases. This adoption aims to consolidate diverse genomic workflows and streamline the analysis of complex genomic data across multiple indications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief on February 09, 2026, and is solely responsible for the information contained therein.